ArticleRheumatology international2023

Ixekizumab for brodalumab-induced articular involvement in psoriatic arthritis: beyond IL-17A inhibition.

Tomoyuki Mutoh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.